The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Frohlich Mark W since 2009.
The trader's CIK number is 1420482.
At the time of the last reporting, Frohlich Mark W was the SVP,CA & MO of Juno Therapeutics, Inc.. (stock ticker symbol JUNO).
Also see all insider trading activities at Juno Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | DNDN | 0 | $0 | 5,917 | $71,140 | 0 | $0 |
| 2011 | DNDN | 0 | $0 | 44,577 | $1,431,011 | 18,510 | $99,156 |
| 2010 | DNDN | 0 | $0 | 67,927 | $3,297,647 | 37,671 | $190,212 |
| 2009 | DNDN | 0 | $0 | 21,413 | $513,948 | 26,628 | $123,042 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | JUNO | 0 | $0 | 20,000 | $717,480 | 0 | $0 |
2. Juno Therapeutics, Inc. (JUNO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-04-23 | DNDN | Sale | 2,687 | 10.56 | 28,388 |
| 2012-01-23 | DNDN | Sale | 3,230 | 13.24 | 42,752 |
| 2011-11-14 | DNDN | Sale | 7,500 | 7.20 | 54,000 |
| 2011-11-14 | DNDN | Option Ex | 1,248 | 4.90 | 6,115 |
| 2011-10-21 | DNDN | Sale | 3,230 | 10.17 | 32,839 |
| 2011-08-04 | DNDN | Option Ex | 11,362 | 5.39 | 61,241 |
| 2011-07-21 | DNDN | Sale | 3,230 | 39.13 | 126,402 |
| 2011-06-06 | DNDN | Option Ex | 5,900 | 5.39 | 31,800 |
| 2011-05-03 | DNDN | Sale | 18,000 | 40.63 | 731,376 |
| 2011-04-21 | DNDN | Sale | 3,230 | 40.48 | 130,750 |
| 2011-04-14 | DNDN | Sale | 4,282 | 40.00 | 171,280 |
| 2011-01-21 | DNDN | Sale | 2,250 | 35.27 | 79,346 |
| 2011-01-18 | DNDN | Sale | 2,855 | 36.78 | 105,018 |
| 2010-12-03 | DNDN | Sale | 7,896 | 38.44 | 303,538 |
| 2010-10-18 | DNDN | Sale | 2,855 | 37.68 | 107,564 |
| 2010-08-04 | DNDN | Sale | 4,283 | 40.00 | 171,320 |
| 2010-06-10 | DNDN | Option Ex | 28,377 | 5.20 | 147,560 |
| 2010-04-30 | DNDN | Sale | 43,599 | 54.44 | 2,373,529 |
| 2010-04-06 | DNDN | Option Ex | 3,098 | 4.61 | 14,281 |
| 2010-04-06 | DNDN | Sale | 3,098 | 40.00 | 123,920 |
| 2010-03-09 | DNDN | Option Ex | 4,876 | 4.61 | 22,478 |
| 2010-03-09 | DNDN | Sale | 4,876 | 36.00 | 175,536 |
| 2010-02-16 | DNDN | Sale | 1,320 | 32.00 | 42,240 |
| 2010-02-16 | DNDN | Option Ex | 1,320 | 4.46 | 5,893 |
| 2009-12-01 | DNDN | Option Ex | 5,215 | 4.52 | 23,571 |
| 2009-09-17 | DNDN | Sale | 4,750 | 28.00 | 133,000 |
| 2009-09-17 | DNDN | Option Ex | 4,750 | 4.41 | 20,947 |
| 2009-06-02 | DNDN | Sale | 7,181 | 24.00 | 172,344 |
| 2009-06-02 | DNDN | Option Ex | 7,181 | 4.46 | 32,063 |
| 2009-04-30 | DNDN | Option Ex | 9,482 | 4.90 | 46,461 |
| 2009-04-30 | DNDN | Sale | 9,482 | 22.00 | 208,604 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-02-29 | JUNO | Sale | 20,000 | 35.87 | 717,480 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Frohlich Mark W (SVP,CA & MO of Juno Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.